Aarti Drugs Limited — Board Meeting, 18-07-2025: Outcome of Board Meeting

Aarti Drugs has announced a board meeting where it approved the audited consolidated financial results for the quarter ended June 30, 2025. The company reported a total income of Rs 555.34 Cr and a net profit of Rs 53.97 Cr. This reflects good year-on-year growth, with income up from Rs 539.71 Cr and profit from Rs 43.98 Cr in the prior year's same quarter. Additionally, the board approved the appointment of M/s. Mehta & Mehta as Secretarial Auditors for five years, pending shareholder approval, enhancing governance.